Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Table 2 Bowel complications associated with cytoreductive surgery and perioperative intra-peritoneal chemotherapy

Authors, yr	Patients (n)	Ratio anast/patient	Protective ostomy (%)	BC/A ratio (%)	Bowel complications rate (%)	Risk factors for bowel complications
Jacquet et al[21], 1996	60	1.8	None	9.3	17	Duration, No. of peritonectomy procedures1
Stephens et al[10], 1999	200	NA	NA	NA	7.5	Intraoperative blood loss1
Witkamp et al[30], 2001	46	2	39	17.4	34
Elias et al[31], 2001	64	2.6	NA	8	18.8
Elias et al[32], 2003	36	2.8	NA	7.2	22.2
Parvaiz et al[33], 2002	43	NA	NA	NA	5
Glehen et al[11], 2003	56	0.6				Carcinomatosis extent, duration, No. of anastomoses1
Glehen et al[34], 2003	73		NA	NA	10.7
Verwaal et al[22], 2004	102	> 2	42	NA	17.6
Shen et al[35], 2004	77	NA	13	NA	NA

¹On univariate analysis. anast: Anastomoses; BC/A: Bowel complications/Anastomoses ratio; NA: Not available.